Amicus Therapeutics Earning Date (FOLD)

USA |NASDAQ |USD

FOLD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 28, 2022 Dec 2021 $-0.18 - $-0.27
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 28, 2022 Dec 2021 $86.33M - $70.57M

Amicus Therapeutics's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 2021.

FOLD Earnings Date & History Chart

FOLD Earnings & Revenue Forecast

FOLD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 11 $-0.33 $-0.69 $0.10

FOLD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 7 / 1 $-0.51 $-0.51 $-0.54

FOLD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 11 $425.82M $389.70M $498.07M

FOLD Earnings Date & Revenue History

FOLD Earnings History

|
Show More
Show More

FOLD Revenue History

|
Show More
Show More

Amicus Therapeutics Next Earnings Date & Report

FOLD Next Earnings Date & Report Preview: Dec 2021 (FQ)

FOLD's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Amicus Therapeutics's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.27, and a high estimation of $-0.10.

Over the last 1 month, EPS estimates have seen 3 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.18, and the 3 month trend is $-0.19.

Based on analysts, the average revenue estimation is $86.33M, with a low revenue estimation of $81.30M, and a high estimation of $88.10M.

Amicus Therapeutics Previous Earnings Dates & Reports

FOLD Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Amicus Therapeutics's previous earnings date was Nov 3, 2021 for its fiscal quarter ended Sep 30, 2021.

FOLD Previous Earnings Date & Report Recap: Dec 2020 (FY)

Amicus Therapeutics's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

FOLD's earnings per share (EPS) was $-1.07, missing the consensus analysts forecast of $-1.02 by 4.90% , and higher than the previous year's EPS (Dec 2019) by -29.14%.

Revenues were $260.89M, better than the forecast of $259.93M by 0.37%, and up by 43.16% from previous year's revenue.

The company reported a net income of $-276.85M.

Amicus Therapeutics reported a free cash flow of $-236.52M for its fiscal year, compared to $-270.43M a year ago.

The company ended the fiscal year with $396.13M in total debt, an increase of 152.80% compared to the previous year.